Werewolf Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Werewolf Therapeutics

12/08/2021 14:31

* Werewolf Therapeutics Inc  HOWL.OQ  reported a quarterly
adjusted loss of $3.82​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 37 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Werewolf Therapeutics Inc's reported EPS for the quarter was a
loss of $3.82​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Werewolf Therapeutics Inc shares had fallen by 14.2% this
quarter.
* The company reported a quarterly loss of $67.85 million.
* Wall Street's median 12-month price target for Werewolf
Therapeutics Inc is $26.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated